These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30814315)

  • 1. Prognostic value of some inflammatory markers in patients with lymphoma.
    Hamed Anber N; El-Sebaie AH; Darwish NHE; Mousa SA; Shamaa SS
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30814315
    [No Abstract]   [Full Text] [Related]  

  • 2. High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma.
    Paradisi R; Vicenti R; Macciocca M; Seracchioli R; Rossi S; Fabbri R
    Fertil Steril; 2016 Oct; 106(5):1176-1182. PubMed ID: 27430206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of cytokines and prevalence of autoantibodies in lymphoma patients and their prognostic value.
    Uskudar Teke H; Gulbas Z; Bal C
    J BUON; 2014; 19(1):191-7. PubMed ID: 24659663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.
    Prondzinsky R; Unverzagt S; Lemm H; Wegener N; Heinroth K; Buerke U; Fiedler M; Thiery J; Haerting J; Werdan K; Buerke M
    Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):476-84. PubMed ID: 22810435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local and systemic release of cytokines, nerve growth factor, prostaglandin E2, and substance P in incisional wounds and serum following cesarean delivery.
    Carvalho B; Clark DJ; Angst MS
    J Pain; 2008 Jul; 9(7):650-7. PubMed ID: 18394968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of suppressor of cytokines signalling-3 mRNA expression from patients with non-Hodgkin lymphoma under chemotherapy.
    Attia FM; Hassan AM; El-Maraghy NN; Ibrahium GH
    Cancer Biomark; 2011-2012; 11(1):41-7. PubMed ID: 22820139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential diagnostic and prognostic value of serum cytokines (soluble CD30, soluble interleukin-2 receptor, interleukin-10 and interleukin-6) in Hodgkin's disease and lymphosarcomas].
    Iaguzhinskaia OE; Lazarev IE; Nikitin EA; Samoĭlova RS; Loginova IV; Gemdzhan EG; Novikov VA; Mamiliaeva ZKh; Pivnik AV
    Ter Arkh; 2001; 73(4):45-51. PubMed ID: 11494447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma.
    Stasi R; Zinzani L; Galieni P; Lauta VM; Damasio E; Dispensa E; Dammacco F; Venditti A; Del Poeta G; Cantonetti M
    Eur J Haematol; 1995 Jan; 54(1):9-17. PubMed ID: 7859883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulated plasma levels of colony-stimulating factors, interleukin-6 and interleukin-10 in patients with acute leukaemia and non-hodgkin's lymphoma undergoing cytoreductive chemotherapy.
    Reisbach G; Kamp T; Welzl G; Geiz C; Abedinpour Fariborz ; Lodri A; Kaboth W; Dörmer P; Nerl C
    Br J Haematol; 1996 Mar; 92(4):907-12. PubMed ID: 8616084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated adiponectin, omentin, increased interleukin-6 and tumor necrosis factor-alpha levels with altered cognition and depression in non-Hodgkin lymphoma patients: A case-control study.
    Kathpalia M; Mishra P; Majid A; Khan MA; Sharma A; Bhurani D; Nidhi
    J Neuroimmunol; 2024 Jul; 392():578372. PubMed ID: 38788317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype.
    Edlefsen KL; Martínez-Maza O; Madeleine MM; Magpantay L; Mirick DK; Kopecky KJ; LaCroix AZ; De Roos AJ
    Int J Cancer; 2014 Aug; 135(4):913-22. PubMed ID: 24488825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cytokine profiles at diagnosis in pediatric patients with non-hodgkin lymphoma.
    Mellgren K; Hedegaard CJ; Schmiegelow K; Müller K
    J Pediatr Hematol Oncol; 2012 May; 34(4):271-5. PubMed ID: 22430582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.
    Conroy SM; Maskarinec G; Morimoto Y; Franke AA; Cooney RV; Wilkens LR; Goodman MT; Hernadez BY; Le Marchand L; Henderson BE; Kolonel LN
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):337-47. PubMed ID: 23300021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of some biochemical markers as prognostic factors in malignant lymphoma.
    Khalifa KA; Alkilani AA; Ismail H; Soliman MA
    J Egypt Natl Canc Inst; 2008 Mar; 20(1):47-54. PubMed ID: 19847281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FACTORS ASSOCIATED WITH INCREASED RED BLOOD CELLS TRANSFUSION REQUIREMENTS IN PATIENTS WITH HODGKIN AND NON-HODGKIN LYMPHOMA.
    Ali S; Ali M; Badar F; Basit A; Hameed A
    J Ayub Med Coll Abbottabad; 2015; 27(1):70-3. PubMed ID: 26182741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood levels of pro-inflammatory and anti-inflammatory cytokines during an oral glucose tolerance test in patients with symptoms suggesting reactive hypoglycemia.
    Eik W; Marcon SS; Krupek T; Previdelli IT; Pereira OC; Silva MA; Bazotte RB
    Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27409331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
    Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
    J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for inadequate stem cell mobilization in Chinese patients with NHL and HL: 14-year experience of a single-center study.
    Han X; Ma L; Zhao L; He X; Liu P; Zhou S; Yang J; Qin Y; Yang S; Yao J; Shi Y
    J Clin Apher; 2012; 27(2):64-74. PubMed ID: 22298390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.